Acta Scientific Cancer Biology

Research Article Volume 1 Issue 5

Assessment of Health Related Quality of life in End Stage Renal Disease (ESRD) Undergoing Twice and Thrice weekly Hemodialysis

Ashokkumar Sharma1*, Arezou Ahmadi RA1, Narendra Bheemraj Pariahar1, Manjusha Sajith2, Sunil Jawale3 and SM Ambike4

1Pharm.D Program, Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Pune, Maharashtra, India
2M. Pharm (Perusing Ph.D), Assistant Professor, Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth University Pune, Maharashtra, India
3DM Nephrology, Assistant Professor, Department of Nephrology, Bharati Hospital and Research centre, Pune, Maharashtra, India
4MD Medicine, Consultant Nephrologist, Department of Nephrology, Jehangir Hospital, Pune, Maharashtra, India

*Corresponding Author: Ashokkumar Sharma, Pharm.D Program, Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Pune, Maharashtra, India.

Received: March 25, 2020; Published: April 08, 2020

×

Hemodialysis is most effective maintenance therapeutic technique used in patients with End-Stage Renal Disease (ESRD). However, it is lifelong therapy and requires frequent hospital or dialysis centres visits hampering the patient’s overall quality of life. So, the aim of our study is to assess Health Related Quality of life in End-Stage Renal Disease (ESRD) Undergoing Twice and Thrice weekly Haemodialysis. A prospective observational, cross-sectional study was carried out from August 2016 to July 2017 in patients undergoing hemodialysis. WHOQOL-BREF questionnaire was used to access Health Related Quality of Life. Majority of respondents were male (71.55%), married (88.62%), employed (58.54%), belonging to middle class (69.92%) and residing in rural areas (62.61%). Average mean age was 51.61 ± 15.67 years. Average Quality of Life scores observed in twice weekly and thrice weekly hemodialysis was 51.49 ± 2.52 and 52.87 ± 4.17 respectively. Patients undergoing thrice weekly hemodialysis had improved haemoglobin, serum urea, serum creatinine, blood pressure (10.28 gm/dL, 95.85 mg/dL, 8.32 mg/dL,150 ± 24.31 mmHg and 78 ± 14.87 mmHg) as compared to twice weekly hemodialysis (9.23 gm/dL, 104.94 mg/dL and 8.68 mg/dL, 154 ± 22.77 mmHg and 87 ± 16.38 mmHg). Our study concluded that there was no significant difference between overall Health Related Quality of Life in Twice weekly and Thrice weekly Hemodialysis. Frequent hemodialysis was associated with improved control of hypertension, serum urea, serum creatinine levels.

Keywords: Health Related Quality of Life; Twice and Thrice Weekly Hemodialysis; End Stage Renal Disease; WHOQOL-BREF Questionnaire

×

References

  1. Abraham S., et al. “Assessment of quality of life in patients on hemodialysis and the impact of counselling”. Saudi Journal of Kidney Diseases and Transplantation 23 (2012): 953-957.
  2. C hauhan R and Mendonca S. “Adequacy of twice weekly hemodialysis in end stage renal disease patients at a tertiary care dialysis centre”. Indian Journal of Nephrology 25 (2015): 329-233.
  3. Lin CC., et al. “The phenomenology of deciding about hemodialysis among Taiwanese”. Western Journal of Nursing Research 27 (2005): 915-229.
  4. Yi-Chun Tsai., et al. “Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease”. Nephrology Dialysis Transplantation 25 (2015): 1621-1626.
  5. Skevington SM and Tucker C. “Designing response scales for cross-cultural use in health care: Data from the development of the UK WHOQOL”. Psychology and Psychotherapy 72 (1999): 51-61.
  6. Harper A and Power M. “WHOQOL User manual; Edinburgh (1999).
  7. Paul J Roderick Robin., et al. “Smaller kidney size at birth in South Asians: findings from the Born in Bradford birth cohort study”. Nephrology Dialysis Transplantation 31 (2016): 455-465.
  8. Anu V., et al. “Quality of Life of Patients undergoing Haemodialysis at B.P. Koirala Institute of Health Sciences”. Journal of Manmohan Memorial Institute of Health Sciences 1 (2014): 2.
  9. Silbiger SR and Neugarten J. “The role of gender in the progression of renal disease”. Advances in Renal Replacement Therapy 10 (2003): 3-14.
  10. Stevens PE and Levin A. “Evaluation and management of chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline”. Annals of Internal Medicine 158 (2013): 825-830.
  11. Suja A., et al. “Economic evaluation of end stage renal disease patients undergoing hemodialysis”. Journal of Pharmacy and Bioallied Sciences 4 (2012): 107-111.
  12. Santosh A., et al. “Socio demographic and economic factors associated with people on Hemo-dialysis in a tertiary care hospital, Davangere: A cross sectional study”. National Journal of Research in Community Medicine 5 (2016): 241-245.
  13. Bapat U., et al. “Perceived illness intrusion among patients on hemodialysis”. Saudi Journal of Kidney Disease and Transplantation 20 (2009): 386-391.
  14. Murali R., et al. “Assessment of quality of life in chronic kidney disease patients using the kidney disease quality of life-short form ™ questionnaire in Indian population: A community based study”. Asian Journal of Pharmaceutical and Clinical Research 8 (2015): 271-274.
  15. Hodges VM., et al. “Pathophysiology of anemia and erythrocytosis”. Critical Reviews in Oncology/Hematology 64 (2007): 139-158.
  16. Noorul Amin., et al. “Evaluating Urea and Creatinine Levels in Chronic Renal Failure Pre and Post Dialysis:A Prospective Study”. Journal of Cardiovascular Disease 2 (2014): 182-185.
  17. National Kidney Foundation NKF/DOQI. “Clinical practice guidelines and clinical practice recommendations, 2006 updates hemodialysis adequacy, peritoneal dialysis adequacy, vascular access”. American Journal of Kidney Diseases 48 (2006): S1.
  18. Hegstrom RM., et al. “Hemodialysis in the treatment of chronic uremia”. The American Society for Artificial Internal Organs 7 (1961): 136-152.
  19. Schribner BH., et al. “Why thrice weekly dialysis?” Hemodialysis International 8 (2004): 188-192.
  20. Eschbach JW., et al. “Unattended overnight home hemodialysis”. The American Society for Artificial Internal Organs 12 (1961): 346-359.
  21. Saeed A., et al. “Hemodialysis twice versus three times a week in patients with residual kidney function: quality of life, cardiovascular outcomes and mortality”. Regional Activity-Based HTA (2014): 76.
×

Citation

Citation: Ashokkumar Sharma., et al. “Assessment of Health Related Quality of life in End Stage Renal Disease (ESRD) Undergoing Twice and Thrice weekly Hemodialysis". Acta Scientific Pharmacology 1.5 (2020): 06-12.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US